Summary:
A phase 4 multicenter, multinatioan, prospective, randomized, placebo-controlled, double-blinded parallel group study lasting 12 weeks with 5 office visits to assess efficacy of treatment of IBS-D.
Qualified Participants Must:
• Be between 18 and 80 years of age
•
Be diagnosed with IBS-D or symptoms of IBS-D with symptoms of pain and cramping
•
Have no other bowel diseases
•
Have no history of chronic constipation
•
Have never had Gallbladder removed
Qualified Participants May Receive:
Study medication, study labs and exams and compensation at each completed visit.